ALNY
E446844
ALNY is the stock ticker symbol for Alnylam Pharmaceuticals, a biotechnology company specializing in RNA interference (RNAi) therapeutics.
Observed surface forms (1)
| Surface form | Occurrences |
|---|---|
| Alnylam Pharmaceuticals, Inc. | 0 |
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ stock ticker symbol ⓘ |
| collaboratesWith |
Novartis
NERFINISHED
ⓘ
Regeneron Pharmaceuticals NERFINISHED ⓘ Sanofi (historical collaboration) NERFINISHED ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| develops |
AMVUTTRA (vutrisiran)
NERFINISHED
ⓘ
GIVLAARI (givosiran) NERFINISHED ⓘ ONPATTRO (patisiran) NERFINISHED ⓘ OXLUMO (lumasiran) NERFINISHED ⓘ |
| employs | scientists specializing in RNA interference ⓘ |
| focusesOn |
RNAi-based drugs
ⓘ
genetic medicines ⓘ |
| foundedBy |
David Bartel
NERFINISHED
ⓘ
David R. Corey NERFINISHED ⓘ John Maraganore NERFINISHED ⓘ Other co-founders associated with RNAi field ⓘ Paul Schimmel NERFINISHED ⓘ Phil Zamore NERFINISHED ⓘ Phillip A. Sharp NERFINISHED ⓘ Thomas Tuschl NERFINISHED ⓘ |
| foundedIn | 2002 ⓘ |
| hasAbbreviation | Alnylam NERFINISHED ⓘ |
| hasCUSIP | 02043Q107 ⓘ |
| hasISIN | US02043Q1076 ⓘ |
| hasKeyPerson |
John Maraganore
NERFINISHED
ⓘ
Yvonne Greenstreet NERFINISHED ⓘ |
| hasModality | gene silencing ⓘ |
| hasPipeline | RNAi therapeutics in clinical development ⓘ |
| hasTherapeuticArea |
cardiometabolic diseases
ⓘ
central nervous system diseases ⓘ hepatic infectious diseases ⓘ rare diseases ⓘ |
| headquartersLocation | Cambridge, Massachusetts, United States NERFINISHED ⓘ |
| industry | biotechnology ⓘ |
| languageOfWork | English ⓘ |
| listedOn | NASDAQ ⓘ |
| regulatoryRegion | United States Food and Drug Administration jurisdiction ⓘ |
| represents | Alnylam Pharmaceuticals, Inc. NERFINISHED ⓘ |
| specializesIn |
RNA interference therapeutics
ⓘ
RNAi therapeutics ⓘ |
| targets | mRNA for degradation via RNAi ⓘ |
| technology | RNA interference ⓘ |
| tickerSymbol | ALNY NERFINISHED ⓘ |
| tradedAs | NASDAQ:ALNY NERFINISHED ⓘ |
| usesDeliveryPlatform |
GalNAc conjugate delivery
ⓘ
lipid nanoparticle delivery ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.